Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia.

International journal of clinical pharmacology and therapeutics - 1 Jun 2014

Nagayama Daiji, Murano Takeyoshi, Saiki Atsuhito, Shirai Kohji, Tatsuno Ichiro

Abstract excerpt

OBJECTIVE: Although the C5 variant of cholinesterase is known to be a cause of hypercholinesterasemia, the pathophysiological significance of the C5 variant and the C5 variant-related hypercholinesterasemia in cardiovascular diseases remain unclear. The present study aimed to clarify the pathophy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterases
Share to Coronary Artery Disease
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Multivariate Analysis

Share to Outpatients

Share to Up-Regulation

Source

Identifiers

PMID: 24755128
DOI: 10.5414/CP202009

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24755128-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia.PMID 24755128Read ↗

Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control studySemantic proximity Read ↗

Butyrylcholinesterase: Association with the Metabolic Syndrome and Identification of 2 Gene Loci Affecting ActivitySemantic proximity Read ↗

Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran.Semantic proximity Read ↗

ALDH2 Glu504Lys polymorphism and susceptibility to coronary artery disease and myocardial infarction in East Asians: a meta-analysis.Semantic proximity Read ↗

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A).Semantic proximity Read ↗

[Evaluation of screening methods for cholinesterase variants from daily laboratory data].Semantic proximity Read ↗

Mutation in ST6GALNAC5 identified in family with coronary artery disease.Semantic proximity Read ↗

Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.Semantic proximity Read ↗

H558R polymorphism in SCN5A is associated with Keshan disease and QRS prolongation in Keshan disease patients.Semantic proximity Read ↗

Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.Semantic proximity Read ↗

Identification of a Functional PDE5A Variant at the Chromosome 4q27 Coronary Artery Disease Locus in an Extended Myocardial Infarction Family.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.